|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Merck’s Julie Gerberding, Former CDC Director, on the Future of Vaccines
|
Luke Timmerman |
06/24/11 |
National
|
|
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business
|
Ryan McBride |
01/03/11 |
Boston
|
|
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer
|
Luke Timmerman |
04/29/10 |
Seattle
|
|
Top Five Biotech Innovations of the 2000s
|
Jay Lichter |
12/31/09 |
San Diego
|
|
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines
|
Luke Timmerman |
08/25/09 |
San Diego
|
|
VC Rick Klausner on the Future of Vaccines, and Why Dendreon is Only Scratching the Surface
|
Luke Timmerman |
08/19/09 |
Seattle
|
|
UW’s Gardasil Windfall, Cell Therapeutics Unloads Zevalin, Trubion Cuts Jobs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/26/09 |
Seattle
|
|
Amazon and Madrona Back Yieldex, UW Benefits from Merck Sales, Digini and Vyk Merge, & More Seattle-Area Deals News
|
Gregory T. Huang |
02/24/09 |
Seattle
|
|
UW’s Gardasil Connection Generates Windfall for Research, Tech Transfer
|
Luke Timmerman |
02/23/09 |
Seattle
|
|
Out With the Old Shots, In With the New: Xconomy Forum To Explore Disruptive Changes in Vaccines
|
Luke Timmerman |
12/05/08 |
Seattle
|
|
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/04/08 |
Seattle
|
|
The Pros (and Not Many Cons) of Merck’s HPV Vaccine, According to UW’s Laura Koutsky
|
Luke Timmerman |
12/03/08 |
Seattle
|
|
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks
|
Luke Timmerman |
11/17/08 |
Seattle
|
|
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream
|
Luke Timmerman |
11/10/08 |
San Diego
|
|
Immune Design Aiming To Make Vaccines That Work Better in a Single Shot
|
Luke Timmerman |
07/07/08 |
Seattle
|
|
Immune Design, Led By Star Scientists, Raises $18 Million To Build Vaccine Company
|
Luke Timmerman |
06/23/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.